论文信息 - RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia. - 字舞流文

RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.

Jianxiang Wang | Yue Zhang | T. Qin | Y. Mi | Zhijian Xiao | Jianyong Li | Ze-feng Xu | Lin Yang | Xiao-tang Ma | Liang Liu